SCHEMBL866796

SCHEMBL866796

Clc1ccc(C2(CC3CC3)CO2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 6/20 0.37
SLC6A4 P31645 5/20 0.37
SLC6A2 P23975 3/20 0.37
CHRNA1 P02708 2/20 0.37
CHRNG P07510 2/20 0.37
CHRNB1 P11230 2/20 0.37
CHRNB2 P17787 2/20 0.37
CHRNB4 P30926 2/20 0.37
CHRNA3 P32297 2/20 0.37
CHRNA4 P43681 2/20 0.37
CHRND Q07001 2/20 0.37
MAOA P21397 2/20 0.36
MAOB P27338 2/20 0.36
KDM1A O60341 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRL1 P41146 1/20 0.36
UTS2R Q9UKP6 2/20 0.35
NPSR1 Q6W5P4 1/20 0.34
PTGS2 P35354 1/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL867470 0.82 UTS2R (0.36) SLC6A3SLC6A4SLC6A2CHRNA1CHRNG
SCHEMBL25326027 0.81 SLC6A3 (0.37) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL10638461 0.76 UTS2R (0.38) SLC6A3SLC6A4SLC6A2CHRNA1CHRNG
SCHEMBL10876682 0.75 SLC6A4 (0.40) SLC6A3SLC6A4SLC6A2CHRNA1CHRNG
SCHEMBL11044632 0.75 UTS2R (0.40) SLC6A3SLC6A4SLC6A2CHRNA1CHRNG
SCHEMBL9667369 0.75 SLC6A4 (0.41) SLC6A3SLC6A4SLC6A2CHRNA1CHRNG
SCHEMBL10434640 0.72 UTS2R (0.35) SLC6A3SLC6A4SLC6A2CHRNA1CHRNG
SCHEMBL8807095 0.72 UTS2R (0.38) SLC6A3SLC6A4SLC6A2CHRNA1CHRNG
SCHEMBL11273687 0.69 UTS2R (0.40) SLC6A3SLC6A4SLC6A2CHRNA1CHRNG
SCHEMBL9137411 0.67 SLC6A4 (0.36) SLC6A3SLC6A4SLC6A2CHRNA1CHRNG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440535-A1 ANTIFUNGAL 1,2,4-TRIAZOLYL DERIVATIVES HAVING A 5- SULFUR SUBSTITUENT BASF SE (DE) 2012-04-18 EP disclosed
US-20120077676-A1 Antifungal 1,2,4-Triazolyl Derivatives Having a 5-Sulfur Substituent BASF SE (DE) 2012-03-29 US disclosed
WO-2010142779-A1 ANTIFUNGAL 1,2,4-TRIAZOLYL DERIVATIVES HAVING A 5- SULFUR SUBSTITUENT BASF SE (DE) 2010-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077676-A1 Antifungal 1,2,4-Triazolyl Derivatives Having a 5-Sulfur Substituent ERG28, STS, CYP51A1 SLC6A3 3106/4885SLC6A4 2501/4885SLC6A2 4178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.